Allergy Therapeutics plc announced the appointment of Cheryl Faye MacDiarmid as a Non-Executive Director of the company, effective October 27, 2021. Upon appointment Cheryl will also become a member of the Audit Committee. Cheryl has more than 25 years' experience in commercial roles within the global pharmaceuticals sector. She brings significant marketing, strategy and management expertise, having worked for GlaxoSmithKline (GSK) since 1993, where she has focussed mainly on the commercial aspects of the business, developing a deep knowledge of sales and marketing operations in North America. Ms. Cheryl Faye MacDiarmid holds or has held the following current directorships in PHIVCO UK Limited, PHIVCO UK II Limited, ViiV Healthcare Finance Limited, ViiV Healthcare Overseas Limited, ViiV Healthcare UK Limited, ViiV Healthcare Trading Services UK Limited, ViiV Healthcare UK (No.3) Limited, ViiV Healthcare UK (No.4) Limited, ViiV Healthcare UK (No.5) Limited, ViiV Healthcare UK (No.6) Limited and ViiV Healthcare UK (No.7) Limited.